PDT Partners’s Aspen Aerogels ASPN Stock Holding History

PDT Partners’s Portfolio ASPN Stock Details ASPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,900	Closed	-$78K	–	717
2020 Q2	$78K	Buy	+11,900	New	+$76.4K	0.01%	639

Other funds holding ASPN

GKFF

George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PDT Partners's ASPN Position: Q3 2020 in Review

PDT Partners sold out of Aspen Aerogels (ASPN) in Q3 2020, closing a stake of 11,900 shares — an estimated $78K sold.

PDT Partners first reported a position in ASPN in Q2 2020 and held it in 1 quarter. The position peaked at $78K in Q2 2020. 72 funds tracked by Wall St. Rank hold ASPN as of Q3 2020.

PDT Partners reported no remaining Aspen Aerogels position as of Q3 2020 after selling out during the quarter.
PDT Partners sold 11,900 Aspen Aerogels shares in Q3 2020, an estimated $78K.
PDT Partners first reported a position in Aspen Aerogels in Q2 2020 and held it in 1 quarter.
PDT Partners's Aspen Aerogels position peaked at $78K in Q2 2020.
72 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2020.

Based on PDT Partners's 13F filing for Q3 2020, filed 16 Nov 2020.